K

Kymera Therapeutics

Biotech company engineering targeted protein degraders

Vice President of Pharmaceutical Development

Bioprocess & BiomanufacturingConfirmed live in the last 24 hours
Full-timeWatertown, MA, USAIn-person

About the Job

Requirements

  • A Ph.D. in Pharmaceutics, Pharmaceutical Sciences, Chemical Engineering, or a related discipline, with 18+ years of relevant pharmaceutical industry experience.
  • Demonstrated success leading pharmaceutical development strategy from discovery through clinical development, with experience supporting commercialization readiness.
  • Strong understanding of preformulation, biopharmaceutics, formulation development, and oral solid dose drug product manufacturing for small molecules.
  • Deep expertise in formulation approaches for poorly soluble compounds, including application of enabling technologies to improve bioavailability and product performance.
  • A proven track record of advancing programs through IND and clinical development milestones and contributing to successful regulatory submissions.
  • Strong knowledge of GMP requirements, regulatory expectations, and evolving industry trends.
  • Experience building and managing high-performing teams and external partnerships.
  • Ability to engage technical teams, executive leadership, external partners, and regulatory agencies effectively.

Responsibilities

  • Define and lead the company’s pharmaceutical development strategy across the portfolio, ensuring alignment with corporate priorities and development timelines.
  • Provide strategic leadership for preformulation, biopharmaceutics, and formulation development activities supporting discovery, preclinical, and clinical-stage programs.
  • Champion innovation in formulation sciences and enabling technologies to address complex drug delivery and bioavailability challenges.
  • Drive development and implementation of phase-appropriate drug product development and manufacturing strategies.
  • Lead a high-performing Pharmaceutical Development team in internal activities and management of an external network of CROs, CDMOs, and strategic partners.
  • Establish scalable processes, operational frameworks, and best practices to support portfolio growth.
  • Provide strategic oversight of outsourced development and manufacturing activities, ensuring quality, timelines, and technical objectives are achieved.
  • Lead CMC-related regulatory strategy for drug product development activities, regulatory submissions, and health authority interactions.
  • Ensure compliance with applicable GMP and regulatory requirements.
  • Represent Pharmaceutical Development in due diligence activities, external collaborations, and interactions with other functions.
  • Contribute to risk assessment, resource prioritization, and investment decisions as a member of the Technical Operations leadership team.
  • Foster cross-functional partnerships across Research, Clinical, Regulatory, Quality, Supply Chain, and Program Management to enable efficient advancement of pipeline programs.

About the Company

Kymera Therapeutics

Biotech company engineering targeted protein degraders

Kymera Therapeutics develops therapies that remove disease-causing proteins using targeted protein degradation. The company’s Pegasus Platform helps identify which proteins to degrade and then uses molecules that recruit the cell’s waste machinery to break down those proteins, aiming to treat cancers and immune diseases. This approach can create multiple drug candidates across different diseases. Kymera’s products are advanced through collaborations, most notably with Sanofi, which supports research, licensing, and milestone-based payments. Unlike traditional drugs that inhibit a protein’s function, Kymera’s strategy eliminates the protein itself, potentially offering new treatment options for patients. The company’s goal is to deliver new, effective medicines by degrading harmful proteins, expanding options in the biopharmaceutical market and addressing unmet medical needs.

Company size
201-500
Company stage
IPO
Headquarters
Watertown, MA
Founded
2016

Recently Posted Jobs

Explore more opportunities at Kymera Therapeutics

See more jobs